Abcodia Abcodia's ROCA Ovarian Cancer Test Could Be Useful in High-Risk Patients, Studies Suggest Premium A pair of studies indicate the test could aid monitoring of high-risk patients, though concerns voiced by the FDA and others are still to be fully addressed. U of Manchester to Run Abcodia Lung Cancer Collaboration From New $27M Biomarker Discovery Center Premium Opening next year with funds from the UK's Medical Research Council, the center will have roughly 12 new mass specs for discovery and targeted proteomics. Abcodia to Launch ROCA Ovarian Cancer Test in UK and US This Year Premium In the UK it initially will be offered through private clinics on a "self-pay" basis, while in the US it will be sold as a laboratory-developed test through Abcodia's CLIA lab. Abcodia Raises $8M to Support Launch of Ovarian Cancer Screening Test The company plans to launch the test, which uses serial CA-125 measurements, in the UK this summer and in the US later this year. Abcodia Taps Caprion's Mass Spec Proteomics Platforms for Cancer Biomarker Development Premium Caprion will use its discovery and targeted mass spec platforms to analyze roughly 400 samples from the UK Collaborative Trial for Ovarian Cancer Screening. Dec 10, 2014 Additional Members Join UK Cancer Consortium Sep 15, 2014 OncoCyte, Abcodia Collaborate on Breast Cancer Dx Sep 20, 2013 In Brief This Week: Life Technologies; PerkinElmer; Agilent; Activiomics, KHK; Cancer Genetics, Roche Servicios; More Aug 30, 2013 4,000-plus Patient Study Suggests ROCA Test Specific Enough for Use as Ovarian Cancer Screening Dx Premium Jun 12, 2013 Abcodia, AIT Collaborate to Validate Cancer Biomarkers Jun 6, 2013 CRUK's Commercial Branch, Abcodia Launch Cancer Biomarker Collaboration Sep 21, 2012 People in the News: Additions to Abcodia Premium Feb 28, 2012 Oslo University Hospital Licenses Colorectal Cancer Markers to OGT for Test Development Premium Feb 17, 2012 Abcodia, VolitionRx Collaborate on Nucleosome-based Dx for Cancer Nov 8, 2011 OGT to Use Protein, MiRNA Platforms in Biomarker-Discovery Pact with Abcodia Premium Nov 7, 2011 Abcodia, OGT Partner on Cancer Biomarker Discovery May 24, 2011 UK Startup Abcodia Raises $1.4M Mar 31, 2011 Startup Abcodia Banking on Preclinical Samples for Better Tests Mar 25, 2011 Movers & Shakers: Mar 25, 2011 Premium Breaking News Liver Cancers Detected With Parallel Mutation, Methylation Liquid Biopsy Approach In Brief This Week: Biocept, Thermo Fisher, Biodesix, More Biological Dynamics Taps Two Firms to Study Utility, Economics of Pancreatic Cancer Detection Test Lucira Health Molecular COVID/Flu Test Gets FDA Emergency Use Authorization Biocare Medical Acquires Empire Genomics The Scan UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways. Survey Sees Genetic Literacy on the Rise, Though Further Education Needed Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds. Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers. FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.